Investment Summary

JLL Partners, Water Street Healthcare Partners and The BroadOak Fund Invest In Solvias

On June 11, 2020, private equity firm JLL Partners, private equity firm Water Street Healthcare Partners and growth capital firm The BroadOak Fund invested in life science company Solvias

Investment Highlights
  • This is JLL Partners’ 7th, Water Street Healthcare Partners’ 12th and The BroadOak Fund’s 9th transaction in the Life Science sector.
  • This is JLL Partners’ 1st, Water Street Healthcare Partners’ 1st and The BroadOak Fund’s 1st transaction in Switzerland.

Investment Summary

Date 2020-06-11
Target Solvias
Sector Life Science
Investor(s) JLL Partners
Water Street Healthcare Partners
The BroadOak Fund
Deal Type Growth Capital

Target

Solvias

Kaiseraugst, Switzerland
Solvias is contract research, development, and manufacturing. The industries the company serves include pharmaceuticals, biotech, medical device, and cosmetics. Solvias was founded in 1999 and is based in Kaiseraugst, Switzerland.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 3

Investor

JLL Partners

New York, New York, United States

Investor Investor Investor Investor


Category Private Equity Firm
Founded 1988
PE ASSETS 5.8B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

JLL Partners, Inc. is a private equity investment firm that invests alongside management in middle-market companies. JLL prefers control investments in sectors such as healthcare services, medical products, food and consumer products, chemicals, broadcasting, transportation, automotive, industrial manufacturing, and distribution. In addition to traditional buyout transaction, JLL also seeks distressed/turnaround situations. JLL Partners was formed in 1988 and is based in New York City.


DEAL STATS #
Overall 34 of 40
Sector (Life Science) 7 of 7
Type (Growth Capital) 3 of 5
Country (Switzerland) 1 of 1
Year (2020) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-09-09 Heads Up Technologies

Addison, Texas, United States

Heads Up Technologies designs, engineers and manufactures complex, proprietary cockpit, cabin, and aircraft electrical components and systems to the business and commercial aviation markets. Heads Up have established itself as a trusted partner in the business aviation segment through longstanding relationships with leading OEMs. Heads Up Technologies was founded in 1985 and is based in Addison, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-13 MedeAnalytics

Richardson, Texas, United States

MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare – how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics was founded in 1994 and is based in Richardson, Texas.

Buy -
Investor

Water Street Healthcare Partners

Chicago, Illinois, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2005
PE ASSETS 6.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.


DEAL STATS #
Overall 43 of 50
Sector (Life Science) 12 of 12
Type (Growth Capital) 11 of 17
Country (Switzerland) 1 of 1
Year (2020) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-05 Safeguard Medical

Huntersville, North Carolina, United States

Safeguard Medical is a provider of products and services to the growing first responder market. Safeguard consists of Combat Medical Systems, Prometheus Medical and Trauma FX Ltd. Together, they create a powerful offering of innovative, high-quality products, kitting capabilities and training programs dedicated to supporting first responders with saving lives. Safeguard Medical was founded in 2020 and is based in Huntersville, North Carolina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-06 Key Surgical

Minneapolis, Minnesota, United States

Key Surgical LLC is a provider of sterile processing and operating room supplies. Key Surgical LLC offers a broad suite of thousands of products and supplies focused on instrument reprocessing, operating room, and patient procedures to over 10,000 facilities in 70 countries.

Sell $850M
DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


DEAL STATS #
Overall 11 of 25
Sector (Life Science) 9 of 20
Type (Growth Capital) 4 of 14
Country (Switzerland) 1 of 1
Year (2020) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-14 seqWell

Beverly, Massachusetts, United States

seqWell provides multiplexed solution for preparing NGS libraries from hundreds to thousands of samples without normalization or additional equipment. seqWell is based in Beverly, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-16 Genomenon

Ann Arbor, Michigan, United States

Genomenon is an AI-driven genomics company that organizes the world’s genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer. Genomenon was founded in 2014 and is based in Ann Arbor, Michigan.

Buy -